Graves' Disease
BLOG: Incredible stories about identical twins
We have heard a lot about identical twins having the same things happening to them in parallel.
Repeat COVID-19 vaccination safe for adults with vaccine-induced subacute thyroiditis
Future COVID-19 vaccination doses are safe for adults who previously had a COVID-19 vaccine-induced subacute thyroiditis, according to study data published in The Journal of Clinical Endocrinology & Metabolism.
Thyroid dysfunction after radioiodine therapy common with Graves’ disease
Among adults with Graves’ disease, thyroid dysfunction was common and often recurrent during the first 12 months after radioiodine treatment, according to findings from the PRAGMA study.
Thyroid symptoms, quality of life improve after total thyroidectomy with Graves’ disease
Adults with Graves’ disease who undergo a total thyroidectomy experience improvements in quality of life and thyroid-specific symptoms both shortly after and longer after surgery, according to findings published in Thyroid.
Thyroidectomy as first-line treatment for Graves’ disease reduces mortality, CVD risk
Adults who underwent a thyroidectomy as first-line treatment for Graves’ disease had lower risks for all-cause mortality and cardiovascular disease than those treated with antithyroid drugs or radioactive iodine, according to study data.
Thyroid eye disease requires joint management with ophthalmologists
Not everyone can agree on what to call thyroid eye disease. For some, it is thyroid-associated ophthalmopathy; for others, it is thyroid-related immune orbitopathy. It has also been referred to as Graves’ orbitopathy.
Should teprotumumab become first-line therapy for thyroid eye disease?
Traditionally, many experts in the field have advocated steroids. More recently, EUGOGO and others have advocated high-dose pulse steroid therapy in TED as that route of administration appears to be less associated with side effects.
Total thyroidectomy decreases thyrotropin receptor antibodies quicker in Graves’ disease
Changes in thyrotropin-binding inhibitory immunoglobulin levels for people with refractory Graves’ disease differed for those undergoing total thyroidectomy vs. radioactive iodine therapy, according to study data.
COVID-19 may trigger Graves’ disease relapse, subacute thyroiditis
Approximately 15% of patients with mild to moderate COVID-19 have thyroid dysfunction, and SARS-CoV-2 may directly affect thyroid morphology and function, worsening preexisting autoimmune thyroid disease, data from a review show.
Gut microbes may play role in Graves’ disease diagnosis, thyroid autoimmunity
The abundance and diversity of intestinal microbiota are reduced in adults with Graves’ disease, and Lactobacillus may be one of the pivotal factors activating autoimmune response, according to data published in Thyroid.